Authors
Đurđa Vukićević
UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Austria
Ursula Rochau
UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Austria
Aleksandar Savić
University of Novi Sad, Faculty of Medicine, Clinical Center of Vojvodina, Clinic for Hematology, Serbia
Monika Schaffner
UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Austria
Milica Jevđević
UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Austria
Igor Stojkov
UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Austria
Gaby Sroczynski
UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Austria
Wolfgang Willenbacher
Medical University, Internal Medicine V, Hematology and Oncology, Innsbruck, Austria
Beate Jahn
UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Austria
Uwe Siebert
Area 4 Health Technology Assessment and Bioinformatics, ONCOTYROL - Center for Personalized Cancer Medicine, Innsbruck, Austria
Harvard Chan School of Public Health, Boston
Massachusetts General Hospital, Institute for Technology Assessment and Department of Radiology